key: cord-0925179-5hx6wiso
authors: Sanabria Diaz, G.; Maja Etter, M.; Melie Garcia, L.; Lieb, J. M.; Psychogios, M.-N.; Hutter, G.; Granziera, C.
title: Brain cortical changes are related to inflammatory biomarkers in hospitalized SARS-CoV-2 patients with neurological symptoms
date: 2022-02-15
journal: nan
DOI: 10.1101/2022.02.13.22270662
sha: 3eb94854a1bcfdaf5eb263ce8296f22b55162d35
doc_id: 925179
cord_uid: 5hx6wiso

Increasing evidence shows that the brain is a target of SARS-CoV-2. However, the consequences of the virus on the cortical regions of hospitalized patients are currently unknown. The purpose of this study was to assess brain cortical gray matter volume (GMV), thickness (Th), and surface area (SA) characteristics in SARS-CoV-2 hospitalized patients with a wide range of neurological symptoms and their association with clinical indicators of inflammatory processes. A total of 33 patients were selected from a prospective, multicenter, cross-sectional study during the ongoing pandemic (August 2020-April 2021) at Basel University Hospital (clinicaltrials.gov NCT04472013). Retrospectively biobank, age- and sex-matched healthy controls with the same image protocol served as controls group. For each anatomical T1w MPRAGE image, the Th and GMV segmentation were performed with the FreeSurfer-5.0. Cortical measures were compared between groups using a linear regression model. The covariates were age, gender, age*gender, MRI magnetic field strength, and total intracranial volume/mean Th/Total SA. The association between cortical features and laboratory variables was assessed using partial correlation adjusting for the same covariates. P-values were adjusted using false discovery rate (FDR). Our findings revealed no significant differences between groups in age, gender, Total GMV, Th, and SA (all P>.05). Patients showed lower GMV in orbitofrontal and cingulate regions. In a subgroup of patients (with CSF-study), we found a significant association between a decreased cortical volume and thickness in frontal, fronto-orbital, and temporal regions and increased CSF protein, CSF blood/albumin ratio, and CSF EN-RAGE levels. Our data suggest that viral-triggered inflammation leads to increased neurotoxic damage in some cortical areas.

association between cortical features and laboratory variables was assessed using partial correlation adjusting for the same covariates. P-values were adjusted using false discovery rate (FDR). Our findings revealed a lower cortical gray matter volume in orbitofrontal and cingulate regions in patients compared to controls. The orbitofrontal grey matter volume was negatively associated with protein levels, CSF-blood/albumin ratio and CSF EN-RAGE level.

CSF EN-RAGE and CSF/Blood-albumin ratio, which are neuroinflammatory biomarkers, were . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022. ; https://doi.org/10.1101/2022.02.13.22270662 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. associated with cortical alterations in gray matter volume and thickness in frontal, orbitofrontal, and temporal regions. Our data suggest that viral-triggered inflammation leads to increased neurotoxic damage in some cortical areas.

Gretel Sanabria-Diaz CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022.

Increasing evidence shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain (1). Following the viral infection, a peripherical immune system reaction leads to a hyperinflammatory response and chronic neuronal dysfunction (2) .

However, the consequences of SARS-CoV-2 in the brain of hospitalized patients, where neurological complications are observed in 80% of the cases, are currently unknown. The purpose of this study was to assess brain cortical gray matter volume (GMV), thickness (Th), and surface-area (SA) characteristics in SARS-CoV-2 hospitalized patients with a wide range of neurological symptoms compared to healthy controls, as well as their association with clinical indicators of inflammatory processes.

A total of 33 patients with SARS-CoV-2 infection were enrolled from a prospective, multicenter, cross-sectional study during the ongoing pandemic (August 2020-April 2021) at Basel University Hospital (clinicaltrials.gov NCT04472013). All participants remained anonymous, and written consent was given by the patients or a legal representative. Inclusion criteria were age>18 years, a reverse transcriptase PCR (rRT-PCR)-positive SARS-CoV-2 infection, and a 3D high-resolution T1-weighted MRI sequence of the whole brain. Exclusion criteria were SARS-CoV-2 RT-PCR-negative testing and pregnancy. A subset of subjects (n=14 to 20) benefitted from cerebrospinal fluid (CSF) sampling. The laboratory test included leukocytes, lactate, protein levels, CSF-blood/albumin-ratio, and five cytokines (plasma-TRANCE, plasma-EN-RAGE, CSF-OPG, CSF-TRANCE, and CSF-EN-RAGE) that had been previously associated with SARS-CoV-2 infection severity (2) . The cytokines analysis was performed using the Olink 96 target inflammation and neurology (https://www.olink.com/productsservices/target/inflammation/) panels. The patients were stratified based on their neurological symptoms (class I: mild neurological symptoms; class II: moderate neurological symptoms;

class III: severe neurological symptoms, Table 1 ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022. ; https://doi.org/10.1101/2022.02.13.22270662 doi: medRxiv preprint Retrospectively biobank, age-and sex-matched healthy controls with the same image protocol served as controls and were obtained from the Neurology Department, University of Basel.

Patient and control characteristics are presented in Table 1 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022. ; https://doi.org/10.1101/2022.02.13.22270662 doi: medRxiv preprint Anatomical T1wMPRAGE MRI sequences were acquired using two MRI scanners: Scanner-1: 1.5Tesla Siemens-Avanto-Fit and Scanner-2: 3Tesla Siemens-Skyra: Scanner-1: 160 slices in sagittal orientation; in-plane FOV= 256×256mm2, matrix size 256×256, voxel size of Clinical and demographic variables were compared between groups with independent t-tests, Mann-Whitney, or Chi-square tests as appropriate. GMV, SA, and Th were compared between groups using a linear regression model. Age, gender, age*gender, MRI-magnetic fieldstrength, total intracranial-volume (TIV)/mean-Th/Total-SA were used as covariates. The associations between cortical measures and laboratory variables were assessed using partialcorrelation and the same covariates. For all analysis P-values were adjusted for multiple comparisons using false discovery rate (FDR). The statistical analysis was performed using the JASP-software (https://jasp-stats.org/) and MATLAB-software for the partial-correlation analysis ('partialcorri.m') (https://www.mathworks.com/). Table 1 . There were no significant differences between groups in age, gender, Total-GMV, mean-Th, and

Total-SA (all P>.05) ( Table 1) .

Patients showed lower GMV in the right rostral anterior cingulate (controls-mean=1.90; patients-mean=0.38; P=.46), left medial orbitofrontal (controls-mean=5.08; patients-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022. Fig 1. Map of the brain regions with a significant association between gray matter volume and cortical thickness clinical variables in severly affected SARS-CoV-2 patients. Panel A) show the 27 brain regions with significant correlation values for gray matter volume and cortical thickness after multiple comparison corrections (False Discovery Rate-FDR). Panel B) and C) shows the matrices representing the association significance (significant p-corrected<0.05 in red squares).CSF=Cerebrospinal fluid, leuk=leukocytes, lact=lactate, prot=protein, albR=Albumin CSF-blood ratio, Cen_Rage: CSF EN-RAGE = extracellular receptor for advanced glycation endproducts binding protein, R= right, L= left.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The highest number of significant negative correlations were found for protein levels (18 regions), CSF/blood/albumin-ratio (15 regions), and the EN-RAGE cytokine (17 regions).

These regions were anatomically localized in frontal, orbitofrontal, and temporal regions ( Fig   A, Fig B) . (Fig 1-A, Fig 1-C) .

Finally, SA showed a significant correlation between the EN-RAGE and the right posterior cingulate cortex (r=.79; P=.04).

This study shows a GMV decrease in orbitofrontal and cingulate regions in a sample of hospitalized SARS-CoV-2 patients with a wide range of neurological symptoms. These findings are in agreement and extend previous reported multifocal MRI abnormalities in hospitalized patients (4) . Interestingly, the GMV in the orbitofrontal area-a region that has been described as metabolic affected in hospitalized patients (5) -was consistently negatively associated with with protein levels, CSF/blood-albumin ratio and CSF EN-RAGE.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022. ; https://doi.org/10.1101/2022.02.13.22270662 doi: medRxiv preprint One hypothesis for the brain alteration in SARS-CoV-2 infection is a neuroinflammatory response (6) . Our results confirmed a significant association between (i) a decreased GMV and Th in frontal, fronto-orbital, and temporal regions and (ii) increased CSF levels of indirect inflammatory markers (protein, blood/albumin ratio, and EN-RAGE). Elevation in CSF protein levels has been used to indicate the inflammatory response (7) . The CSF/blood-albumin ratio increase suggests a BBB breakdown. EN-RAGE is a cytokine that activates an inflammatory cascade, including accelerated atherosclerosis (8) . The relationship between ENRAGE and CSF/blood-albumin ratio with increased volumes in some cortical areas suggests a viraltriggered inflammatory process as a consequence of a secondary parainfectious complication or after direct invasion (less probable) (9).

In summary, CSF inflammatory marker levels were associated with GMV and Th changes in frontal, orbitofrontal, and temporal regions in hospitalized SARS-CoV-2 patients with different levels of neurological involvement. Future longitudinal studies in larger cohorts should further confirm and expand these findings.

Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories

Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

Neuroinflammation and Its Impact on the Pathogenesis of COVID-19

A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19

A novel inflammatory marker for incident coronary heart disease

SARS-CoV-2-specific neuropathology: fact or fiction?

We would like to thank all colleagues for helping us during the current study and the selfless volunteers who participated. We are also very grateful to many members of the frontline medical staff for their selfless dedication in the face of this pandemic.

Guarantors of integrity of entire study, all authors ; study concepts/study design, G. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 15, 2022. ; https://doi.org/10.1101/2022.02.13.22270662 doi: medRxiv preprint